Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer
Noor Hasima(University of Malaya), Bülent Özpolat(The University of Texas MD Anderson Cancer Center)
Cited by 257
Related Papers
Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
|PLoS ONE|2012|118
The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells
|International Journal of Oncology|2015|114
FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
|Oncotarget|2016|114